BackEstrella Immunopharma Overview

Estrella Immunopharma Current Assets

Track Estrella Immunopharma's current assets ($2.2M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$2.16M
↑ 128.45% YoYΔ $1.21M vs prior year quarter

Peer average

Loading

Estrella Immunopharma Current Assets History

Loading

Estrella Immunopharma vs. peers: Current Assets Comparison

Loading

Estrella Immunopharma Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Estrella Immunopharma (ESLA) FAQ

As of the most recent data (March 2026), ESLA shows a current assets of $2.2M. That compares with $940K in the prior-year period — up 128.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ESLA's current assets is now $2.2M (was $940K) — a 128.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Estrella Immunopharma is outperforming or lagging.

Tracking ESLA's current assets over time shows whether Estrella Immunopharma is scaling, shrinking, or reshaping that part of the business. The current reading is $2.2M That compares with $940K in the prior-year period — up 128.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Estrella Immunopharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $2.2M) with ownership activity and broader fundamentals.